Alice Bradbury

Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting

Alice Bradbury, R O’Donnell, Yvette Drew et al. · Cancers · 2020 · 44 citations · Full text

Chemotherapy Response, Cytotoxicity Assays, Oncogenic Agent +14

Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities

John J. Krais, David J. Glass, Ilse Chudoba et al. · Nature Communications · 2023 · 22 citations · Full text

The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response

Alice Bradbury, Frank T. Zenke, Nicola J. Curtin et al. · Cells · 2022 · 15 citations · Full text

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor

Miriam Franklin, Lucy Gentles, Elizabeth Matheson et al. · Cancer Medicine · 2018 · 13 citations · Full text

Gynecology, Pathology, Cell Culture +19

Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer

Sweta Sharma Saha, Lucy Gentles, Alice Bradbury et al. · Cancers · 2021 · 11 citations · Full text